Antiemetic Drugs Market - Forecast(2022 - 2027)

Report Code: HCR 0141 Report Format: PDF + Excel

Antiemetic Drugs Market Overview

Antiemetic Drugs Market size is estimated to reach $6.1 billion by 2027, growing at a CAGR of 5.3% during the forecast period 2022-2027. Antiemetic drugs fall under the category of therapeutic drugs which are taken into account to treat uncontrollable reflexes like nausea and vomiting. This uneasiness or sudden urge to eject the content of the stomach is often triggered by vestibular illnesses, digestion problems, pregnancy, and acts as an emetogenic chemotherapeutic agent. Dopamine receptors, histaminergic receptors, and various antagonists are used as first-line treatments to cure the urge to vomit. With advancements in mediums of transportation and connectivity many people nowadays are prone to motion sickness. While traveling it becomes hard for the brain to figure out whether the body is moving or motionless because various motion-sensing parts confuse it by sending contradictory signals. The outlook for the antiemetic drugs market is remarkably captivating with growing cancer complications worldwide. Heightened mobility of people with escalating per capita income, proliferation in cancer complications are factors set to drive the growth of the Antiemetic Drugs Market for the period 2022-2027.

Report Coverage

The report: “Antiemetic Drugs Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Antiemetic Drugs Market.

By Type: Cannabinoids, Serotonin and Dopamine antagonists, NK1 receptor antagonist, Benzodiazepines, 5-HT3 receptor, Anticholinergic, Steroid-corticosteroids, and others.
By Application: Migraine, Anesthesia, Vestibular illnesses, Pregnancy, Chemotherapy, Opioid analgesics, Palliative care, Gastroenteritis, Opioid-induced nausea.
By Distribution Channel: Offline and Online platforms.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

  • Geographically, the North America Antiemetic Drugs Market accounted for the highest revenue share in 2021. It is owing to the vast array of population receiving chemotherapy treatments which in turn enforces people to start on medications related to antiemetics. However, Asia-pacific is expected to offer lucrative growth opportunities to the marketers in the projected period of 2022-2027 owing to a substantial shift of government’s focus to enhance the medicinal reach and pro-active budget allocation.
  • Enlarging research activities for novel drug discovery is said to be a preeminent driver driving the growth of the Antiemetic Drugs Market. Side-effects connected with the overuse of antiemetic drugs are said to reduce the market growth.
  • Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Antiemetic Drugs Market report.
Antiemetic Drugs Market- Geography (%) for 2021.
Antiemetic Drugs Market
For More Details on This Report - Request for Sample

Antiemetic Drugs Market Segment Analysis-By Application

The Antiemetic Drugs Market based on the application type can be further segmented into migraine, anesthesia, vestibular illnesses (=motion sickness), pregnancy, chemotherapy, opioid analgesics, palliative care, gastroenteritis, opioid-induced nausea. The chemotherapy and pregnancy-induced nausea and vomiting held the largest segment in 2021. The growth in cancer treatment procedures like chemotherapy is owing to the heightened number of cancer patients worldwide. Bad ingestion habits, excess use of alcohol and smoking, worsening pollution situations are some common reasons behind soaring cancer cases. Furthermore, nausea and vomiting are very common during pregnancies which have made usage of antiemetic drugs a norm. The vestibular illnesses and chemo-induced vomiting segment is estimated to be the fastest-growing segment with a CAGR of 5.9% over the forecast period 2022-2027. This growth is owing to the mounting usage of antiemetic drugs during traveling and chemotherapies. Cardiovascular diseases are the leading cause of death around the globe. Around 30-32% of demises worldwide occur due to cancer and heart attacks. Considering the vulnerable immunity, the number is anticipated to rise in foreseeable future.

Antiemetic Drugs Market Segment Analysis-By Distribution Channel

The Antiemetic Drugs Market based on distribution channels can be further segmented into hospital pharmacies, retail pharmacies, drug stores, and others. The hospital segment held the largest share in 2021. The growth is owing to the upsurging number of pregnancy treatments and cancer-associated treatments like chemotherapy. With rapid modernization, a huge shift in attitudes of people from treatments to prevention can be witnessed. Therefore, broadening health awareness among people encourages them to undergo all necessary procedures well in advance. Moreover, the refining infrastructure of hospitals and other medical facilities is contributing factor in the growth of the antiemetic drugs market. There are around 71 NCI designated Cancer hospitals within the 36 states and District of Columbia, which further eases the use of drugs pertaining to nausea. However, the retail pharmacies segment is estimated to be the fastest-growing segment with a CAGR of 6.2% over the forecast period 2022-2027. This growth is owing to the across-the-board presence of retail pharmacies in urban as well as rural areas. On another hand, augmenting the application of antiemetic drugs in the treatment of motion sickness encourages people to buy such medication over-the-counter without any prior prescription from doctors.

Antiemetic Drugs Market Segment Analysis-By Geography

The Antiemetic Drugs Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 34% of the overall market in 2021. The growth in this segment is owing to the factors such as the higher prevalence of breast and lung cancer cases among the American population. Attributing to full-fledged economies North-American people enjoy a high standard of living. Additionally, they have access to the world’s best healthcare facilities such as hospitals and diagnostic laboratories which is a prominent factor fueling the growth in the respective segment. Nevertheless, the Asia-Pacific is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to shooting up cancer prevalence due to the broadening geriatric population, enlarging affluence of Asian nations. As per capita income of Asian states is augmenting people are buying their personal vehicles which are resulting in expansion of traveling trips. The poor quality and unhygienic buses and trains in the nations like India is another factor that stimulated the urge because for impoverished and middle-class sections the public transportation is the most common way of commuting from one place to other. India saw a 137% increase in its healthcare budget allocation which would prove out to help those who need it the most, especially the underprivileged cancer patients requiring chemotherapy.

Antiemetic Drugs Market Drivers

The proliferating pervasiveness of cancer is Anticipated to Boost Product Demand

Following heart-attack cancer is the second biggest cause stimulating the death figures throughout the globe. Every year around 9-10 million people lose their life to it. Breast and lung cancer are the two main categories as their prevalence has augmented on an unprecedented scale. With 2.3 million diagnosed cases in 2020, breast cancer claimed the lives of more than 680,000 people worldwide. Similarly, with the escalating smoking trend, the pervasiveness of lung cancer is growing. According to a study, 82% of lung cancer complications are caused by smoking. On another hand, accruing the old-age population is another prominent factor in the growth of the antiemetic drugs market.

Accruing per capita income is Expected to Boost Product Demand

Rapid modernization and industrialization around the globe are fueling the per capita income of countries. If we compare the last two decades The unemployment rates have reduced as people today have more means to earn a living as compared to earlier times. The trends of buying personal vehicles, exploring the world, and visiting amusement parks have multiplied in recent years which is a prominent factor in the growth of the respective market. More than 17% of the world population has their own cars and the number is expected to accrue in upcoming years as purchasing power is expanding. Many European country’s per capita has crossed the $65000 mark. Besides, the living standard in the so-called third world is improving. People are traveling more than ever with the availability of adequate transportation. All these aforementioned factors are prompting the use of antiemetic drugs.

Antiemetic Drugs Market Challenges

Health hitches associated with overuse of antiemetic drugs are Anticipated to Hamper Market Growth

There are several adverse side effects accompanied by the use of antiemetic drugs which are anticipated to cripple the growth of the antiemetic market. These effects can be life-threatening in a few cases. Anticholinergic effects which include tachycardia, constipation, hallucinations, schizophrenia are connected with the use of dopamine antagonists. Furthermore, antiemetic drugs including serotonin antagonists, benzodiazepines, and cannabinoids may lead to several other health hitches like QT prolongation, extrapyramidal symptoms (=akathisia, dystonia, and parkinsonism), sedition.

Antiemetic Drugs Market Competitive Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Antiemetic Drugs Market. The Top-10 Key companies of Antiemetic Drugs Market are-

  1. Abbott
  2. Sanofi-Aventis
  3. GlaxoSmithKline
  4. F. Hoffmann-La Roche
  5. Merck & Co.
  6. Novartis AG
  7. Baxter International
  8. Eisai Co.
  9. Daiichi Sankyo
  10. Eli Lily and Company

Recent Developments/Product Launches:

  • On November 9, 2021, “Sanofi”, a healthcare company based in Paris, France announced the acquisition of “Kadmon Corporation.” Kadmon is a US-based biopharma company that develops various therapies. Sanofi wrapped up the acquisition process with a payment of $1.9 billion. The existing shareholders are going to get $9.50 per share. Additionally, Sanofi’s price tag has been representing a 79% premium over the Kadmom close price of $5.30. Further, Sanofi has been under pressure owing to its slow drug pipeline presence.
  • On July 14, 2021, Indiana, United States-based pharmaceutical company “Eli Lilly and Company” announced the successful acquisition of biotechnology firm “Protomer technologies.” Protomer is famous for its advanced protein therapy production. The company's proprietary chemical biology-based platform enables the development of therapeutic peptides and proteins with a tunable activity that can be controlled using small molecules. Moreover, the transaction is brought to an end with a payment of $1 billion.
  • On March 15, 2021, a Switzerland-based multinational health firm “F. Hoffman-la Roche” announced that it has reached an agreement with GenMark Diagnostics, a company that provides diagnostic solutions and is headquartered in California, United States. Roche paid $1.8 billion in order to bring the deal to an end. Moreover, every existing shareholder of GenMark will receive $24.05 per share.

Relevant Links:

Asia and ASEAN Herbal Medicines Market – Forecast (2022 - 2027)

Report Code: HCR 1347

Branded Generics Market – Forecast (2022 - 2027)

Report Code: HCR 0255

For more Lifesciences and Healthcare Market reports, please click here

1. Antiemetic Drugs Market Overview
    1.1 Definitions and Scope
2. Antiemetic Drugs Market- Executive Summary
3. Antiemetic Drugs Market – Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Antiemetic Drugs Market – Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Antiemetic Drugs Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Antiemetic Drugs Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Antiemetic Drugs Market – By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Antiemetic Drugs Market- By Type (Market Size –$Million/$Billion) 
    8.1 Cannabinoids
    8.2 Serotonin and Dopamine Antagonist
    8.3 NK1 Receptor Antagonist
    8.4 Benzodiazepines
    8.5 5HT3 Receptor
    8.6 Anticholinergic
    8.7 Steroid-Corticosteroid
    8.8 Others
9. Antiemetic Drugs Market- By Application (Market Size –$Million/$Billion) 
    9.1 Migraine
    9.2 Anaesthesia
    9.3 Vestibular Illnesses
    9.4 Pregnancy
    9.5 Chemotherapy
    9.6 Opioid-Induced Nausea
    9.7 Palliative Care
    9.8 Others
10. Antiemetic Drugs Market- By Distribution Channel (Market Size –$Million/$Billion) 
    10.1 Offline
        10.1.1 Hospital Pharmacies
        10.1.2 Retail Pharmacies
        10.1.3 Drug Stores
        10.1.4 Others
    10.2 Online Platforms
11. Antiemetic Drugs Market - By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 Germany
        11.2.2 France
        11.2.3 UK
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Antiemetic Drugs Market - Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs, and partnerships
13. Antiemetic Drugs Market – Industry Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Antiemetic Drugs Market – Key Company List by Country Premium (Premium)
15. Antiemetic Drugs Market - Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies"
List of Tables

Table 1: Antiemetic Drugs Market Overview 2021-2026
Table 2: Antiemetic Drugs Market Leader Analysis 2018-2019 (US$)
Table 3: Antiemetic Drugs Market Product Analysis 2018-2019 (US$)
Table 4: Antiemetic Drugs Market End User Analysis 2018-2019 (US$)
Table 5: Antiemetic Drugs Market Patent Analysis 2013-2018* (US$)
Table 6: Antiemetic Drugs Market Financial Analysis 2018-2019 (US$)
Table 7: Antiemetic Drugs Market Driver Analysis 2018-2019 (US$)
Table 8: Antiemetic Drugs Market Challenges Analysis 2018-2019 (US$)
Table 9: Antiemetic Drugs Market Constraint Analysis 2018-2019 (US$)
Table 10: Antiemetic Drugs Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Antiemetic Drugs Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Antiemetic Drugs Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Antiemetic Drugs Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Antiemetic Drugs Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Antiemetic Drugs Market Value Chain Analysis 2018-2019 (US$)
Table 16: Antiemetic Drugs Market Pricing Analysis 2021-2026 (US$)
Table 17: Antiemetic Drugs Market Opportunities Analysis 2021-2026 (US$)
Table 18: Antiemetic Drugs Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Antiemetic Drugs Market Supplier Analysis 2018-2019 (US$)
Table 20: Antiemetic Drugs Market Distributor Analysis 2018-2019 (US$)
Table 21: Antiemetic Drugs Market Trend Analysis 2018-2019 (US$)
Table 22: Antiemetic Drugs Market Size 2018 (US$)
Table 23: Antiemetic Drugs Market Forecast Analysis 2021-2026 (US$)
Table 24: Antiemetic Drugs Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 26: Antiemetic Drugs Market By Type of Drug, Revenue & Volume, By 5-HT3 receptor antagonists, 2021-2026 ($)
Table 27: Antiemetic Drugs Market By Type of Drug, Revenue & Volume, By Dopamine antagonists, 2021-2026 ($)
Table 28: Antiemetic Drugs Market By Type of Drug, Revenue & Volume, By Steroid-Corticosteroids, 2021-2026 ($)
Table 29: Antiemetic Drugs Market By Type of Drug, Revenue & Volume, By Benzodiazepines, 2021-2026 ($)
Table 30: Antiemetic Drugs Market By Type of Drug, Revenue & Volume, By NK1 receptor antagonist, 2021-2026 ($)
Table 31: Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 32: Antiemetic Drugs Market By Application, Revenue & Volume, By Chemotherapy, 2021-2026 ($)
Table 33: Antiemetic Drugs Market By Application, Revenue & Volume, By Pregnancy, 2021-2026 ($)
Table 34: Antiemetic Drugs Market By Application, Revenue & Volume, By Motion Sickness, 2021-2026 ($)
Table 35: Antiemetic Drugs Market By Application, Revenue & Volume, By Food Poisoning, 2021-2026 ($)
Table 36: Antiemetic Drugs Market By Application, Revenue & Volume, By Gastroenteritis, 2021-2026 ($)
Table 37: North America Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 38: North America Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 39: South america Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 40: South america Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 41: Europe Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 42: Europe Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 43: APAC Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 44: APAC Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 45: Middle East & Africa Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 46: Middle East & Africa Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 47: Russia Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 48: Russia Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 49: Israel Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 50: Israel Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 51: Top Companies 2018 (US$)Antiemetic Drugs Market, Revenue & Volume
Table 52: Product Launch 2018-2019Antiemetic Drugs Market, Revenue & Volume
Table 53: Mergers & Acquistions 2018-2019Antiemetic Drugs Market, Revenue & Volume

List of Figures

Figure 1: Overview of Antiemetic Drugs Market 2021-2026
Figure 2: Market Share Analysis for Antiemetic Drugs Market 2018 (US$)
Figure 3: Product Comparison in Antiemetic Drugs Market 2018-2019 (US$)
Figure 4: End User Profile for Antiemetic Drugs Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Antiemetic Drugs Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Antiemetic Drugs Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Antiemetic Drugs Market 2018-2019
Figure 8: Ecosystem Analysis in Antiemetic Drugs Market 2018
Figure 9: Average Selling Price in Antiemetic Drugs Market 2021-2026
Figure 10: Top Opportunites in Antiemetic Drugs Market 2018-2019
Figure 11: Market Life Cycle Analysis in Antiemetic Drugs Market
Figure 12: GlobalBy Type of DrugAntiemetic Drugs Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy ApplicationAntiemetic Drugs Market Revenue, 2021-2026 ($)
Figure 14: Global Antiemetic Drugs Market - By Geography
Figure 15: Global Antiemetic Drugs Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 16: Global Antiemetic Drugs Market CAGR, By Geography, 2021-2026 (%)
Figure 17: North America Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 18: US Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 60: U.K Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 93: China Antiemetic Drugs Market Value & Volume, 2021-2026
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Antiemetic Drugs Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Antiemetic Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 122: Russia Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Antiemetic Drugs Market 
Figure 131: Developments, 2018-2019*Antiemetic Drugs Market 
Figure 132: Company 1 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)